![Co-Diagnostics, Inc. logo](/logos/CODX.webp)
Co-Diagnostics, Inc.
NASDAQ:CODX
Overview | Financials
Company Name | Co-Diagnostics, Inc. |
Symbol | CODX |
Currency | USD |
Price | 1.34 |
Market Cap | 42,760,740 |
Dividend Yield | 0% |
52-week-range | 0.981 - 2.23 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Mr. Dwight H. Egan |
Website | https://www.codiagnostics.com |
An error occurred while fetching data.
About Co-Diagnostics, Inc.
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD